Severe Acute Respiratory Syndrome-coronavirus 2 Interstitial Bilateral Pneumonia: A Case Report and Review of Literature

Danilo Coco; Silvana Leanza

doi:10.3889/oamjms.2020.4851

Authors

Danilo Coco Department of General Surgery, Ospedali Riuniti Marche Nord, Pesaro, Italy
Silvana Leanza Department of General Surgery, Carlo Urbani Hospital, Jesi, Ancona, Italy

DOI:

https://doi.org/10.3889/oamjms.2020.4851

Keywords:

Severe acute respiratory syndrome-coronavirus 2, Interstitial bilateral pneumonitis, X-ray, Computed tomography scan

Abstract

In December 2019, novel cases of pneumonia were reported for the 1st time in Wuhan, Hubei, China. A novel virus of the big family of coronavirus (COV) was identified as the pathogen, which causes severe acute respiratory syndrome (SARS). The disease is called COV Disease-19 and then SARS-COV 2. The infectious disease has spread worldwide with major number of patients in China, Italy, Spain, France, and the USA. On March 11, 2020, the WHO declared the outbreak of SARS-CoV-2 a pandemic. Morbidity and mortality of the disease cannot yet estimate but have already seen that lethality appears to be particularly higher in older patients. The aim of this article is to present a characteristic clinical picture as case report SARS-COV 2 pneumonia and to provide an overview of the existing literature.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Hamer OW, Salzberger B, Gebauer J, Stroszczynski C, Pfeifer M. CT morphology of COVID-19: Case report and review of literature. Rofo. 2020;192(5):386-92. https://doi. org/10.1055/a-1142-4094 PMid:32215898

Sahin AR, Erdogan A, Agaoglu PM, Dineri Y, Cakirci AY, Senel ME, et al. 2019 Novel coronavirus (COVID-19) outbreak: A review of the current literature. EJMO. 2020;4(1):1-7. https:// doi.org/10.14744/ejmo.2020.12220

Woo PC, Huang Y, Lau SK, Yuen KY. Coronavirus genomics and bioinformatics analysis. Viruses. 2010;2(8):1804-20. https:// doi.org/10.3390/v2081803 PMid:21994708

Drexler JF, Gloza-Rausch F, Glende J, Corman VM, Muth D, Goettsche M, et al. Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA polymerase gene sequences. J Virol. 2010;84(21):11336-49. https://doi.org/10.1128/jvi.00650-10 PMid:20686038

Yin Y, Wunderink RG. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology. 2018;23(2):130-7. https:// doi.org/10.1111/resp.13196 PMid:29052924

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi. org/10.1016/s0140-6736(20)30183-5 PMid:31986264

Wang C, Horby PW, Harden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;95(10223):470-3. https://doi.org/10.1016/s0140-6736(20)30185-9 PMid:31986257

Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A. Coronavirus disease 2019 (COVID-19): A systematic review of imaging findings in 919 patients. AJR Am J Roentgenol. 2020;215(1):83-93. https://doi.org/10.2214/ajr.20.23034 PMid:32174129

Goldsmith C, Tatti K, Ksiazek T, Rollin PE, Comer JA, Lee WW, et al. Ultrastructural characterization of SARS coronavirus. Emerg Infect Dis. 2004;10(2):320-6. https://doi.org/10.3201/ eid1002.030913 PMid:15030705

Pyrc K, Dijkman R, Deng L, Jebbink MF, Ross HA, Berkhout B, et al. Mosaic structure of human Coronavirus NL63, one thousand years of evolution. J Mol Biol. 2006;364(5):964-73. https://doi.org/10.1016/j.jmb.2006.09.074 PMid:17054987

Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-80.e8. https://doi.org/10.1016/j. cell.2020.02.052 PMid:32142651

Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11(8):875-9. https://doi.org/10.1038/nm1267 PMid:16007097

Tu YF, Chien CS, Yarmishyn AA, Lin YY, Luo YH, Lin YT, et al. A review of SARS-CoV-2 and the ongoing clinical trials. Int J Mol Sci. 2020;21(7):2657. https://doi.org/10.3390/ijms21072657 PMid:32290293

Guan WJ, Ni Z, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708-20.

Yoon SH, Lee YH, Kim JY, Lee YK, Ko H, Kim KH, et al. Chest radiographic and CT findings of the 2019 novel Coronavirus disease (COVID-19): Analysis of nine patients treated in Korea. Korean J Radiol. 2020;21(4):494-500. https://doi.org/10.3348/ kjr.2020.0132 PMid:32100485

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395(10223):507-13. https://doi.org/10.1016/ s0140-6736(20)30211-7 PMid:32007143

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. https://doi.org/10.1001/jama.2020.1585 PMid:32031570

Cockrell AS, Yount BL, Scobey T, Jensen K, Douglas M, Beall A, et al. A mouse model for MERS coronavirus-induced acute respiratory distress syndrome. Nat Microbiol. 2016;2(2):16226. https://doi.org/10.1038/nmicrobiol.2016.226 PMid:27892925

Brown AJ, Won JJ, Graham RL, Dinnon KH 3rd, Sims AC, Feng JY, et al. Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase. Antiviral Res. 2019;169:104541. https://doi.org/10.1016/j. antiviral.2019.104541 PMid:31233808

Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269-71. https://doi.org/10.1038/s41422-020-0282-0 PMid:32020029

Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14(1):72-3. https://doi.org/10.5582/bst.2020.01047 PMid:32074550

Martinez M. Compounds with therapeutic potential against novel respiratory 2019 coronavirus. Antimicrob Agents Chemother. 2020;1:1-18. https://doi.org/10.1128/aac.00399-20

Mehta P, McAuley D, Brown M, Sanchez E, Tattersall R, Manson J. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033-4. https:// doi.org/10.1016/s0140-6736(20)30628-0 PMid:32192578

Shen M, Peng Z, Xiao Y, Zhang L. Modelling the Epidemic Trend of the 2019 Novel Coronavirus Outbreak in China. United States: BioRxiv; 2020. https://doi.org/10.1101/2020.01.23.916726